FDA Inspection 1160650 — mAbxience Research SL
The FDA completed an inspection of mAbxience Research SL on Dec 15, 2021 in Madrid. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 15, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Madrid (Spain)
Additional Details
Sponsor, Contract Research Organization